non-Hodgkin's lymphoma (SMR 107; 20 deaths)-but in none was the increase significant at the 5% level.
Half of the authority's employees were recorded as having been monitored for exposure to radiation, their collective recorded exposure being 660 Sv (65 954 rem). Among these prostatic cancer was the only condition with a clearly increased mortality in relation to exposure. Of the 19 men who had a radiation record and died from prostatic cancer at ages 15-74 years, nine had been monitored for several different sources of exposure to radiation. The standardised mortality ratios were 889 (six deaths) in employees monitored for contamination by tritium, 254 (nine deaths) in those monitored for contamination by other radionuclides, and 385 (nine deaths) in those with dosimeter readings totalling more than 50 mSv (5 rem); but the same nine subjects tended to account for each of these significantly raised ratios. Because multiple exposures were common and other relevant information was not available the reason for the increased mortality from prostatic cancer in this population could not be determined and requires further investigation.
Excess mortality rates of 2 2 and 12 5 deaths per million person years per 10 mSv (1 rem) were estimated for leukaemia and all cancers, respectively. The confidence limits around these estimates were wide, included zero, and made it unlikely that the International Commission on Radiological Protection's cancer risk coefficients were underestimated by more than 15-fold. Thus despite this being the largest British workforce whose mortality has been reported in relation to low level ionising radiation exposure, even larger populations will need to be followed up over longer periods before narrower ranges of risk estimates can be derived.
Introduction
The magnitude of the risk of cancer in people exposed repeatedly to low levels of ionising radiation is the subject of considerable debate. Most estimates of risk, such as those published by the International Commission on Radiological Protection, are based to a large extent on linear extrapolation from the known effects in heavily exposed groups such as survivors of atomic bombs or patients treated with radiotherapy.' Such populations were exposed, over a relatively short period, to doses of ionising radiation often hundreds or thousands of times greater than the total doses typically accumulated over long periods by workers in the nuclear industry. In 1977 Mancuso et al suggested, on the basis of a study of workers at the Hanford nuclear plant in the United States, that extrapolation from highly exposed populations may underestimate cancer risk at low levels of chronic exposure by about 20-fold. 2 Their methods have been criticised and the data reanalysed.3 Nevertheless, the ensuing controversy together with recognition of the need to examine the validity of existing risk estimates for low levels of radiation exposure has prompted several studies in the nuclear industry.
In 1978 the United Kingdom Atomic Energy Authority, desiring an independent inquiry, asked the Medical Research Council to appoint an epidemiological group to investigate the mortality of its employees. Members of the epidemiological monitoring unit at the London School of Hygiene and Tropical Medicine performed this task, the conduct, analysis, and findings of the study being reviewed yearly by an ad hoc subcommittee of the MRC's Protection Against Ionising Radiation Committee (latterly the Committee on the Effects of Ionising Radiation).
The purpose of the study was to examine the mortality of employees of the United Kingdom Atomic Energy Authority, to see if there was any relation between mortality and recorded exposure to ionising radiation, and to compare the findings with risk estimates published by the International Commission on Radiological Protection. Before the investigation began it was recognised that the study would not have sufficient power to detect an increase in radiation related cancers unless the existing figures of the International Commission on Radiological Protection underestimated risk by a factor of about 20 or more.
Methods
The design of the study and methods of data collection and validation are described in our accompanying report (p 435). Personnel records were used to define the study population. Data were collected for all employees of the authority at its establishments at Harwell, Culham, London, Dounreay, Winfrith, Risley, and Culcheth who were in service at any time from 1 January 1946 to 31 December 1979 (except those who had been statutorily transferred, with their records, to British Nuclear Fuels, the Radiochemical Centre, and the Atomic Weapons Research Establishment at the time of their respective formations).
Radiation records held by the authority were used to construct files of employees who had been monitored for exposure to radiation. For those issued with a film badge or other personal dosimeter a yearly summary of the dosimeter recordings was extracted. This included the total "whole body dose," stated here in millisieverts (mSv), and the numbers of dosimeters issued, lost, with readings below the threshold of the measuring devices used, and with readings exceeding 10 mSv (1 rem). Dosimeter readings of whole body dose, which include contributions from x and y rays and neutrons, indicate the amount of radiation from external sources which penetrates the body. Since the doses recorded on dosimeters are not direct measurements of the absorbed dose in the tissues, the term whole body "exposure" rather than "dose" is used here, The study used two main methods of analysis. The first compared the mortality of the study population with that of the general population. Person years at risk were calculated for men and women in each of 12 five year age groups (15-19, 20-24, etc) and seven calendar periods (1946-9, 1950-4, 1955-9, etc Table II shows the standardised mortality ratios for all causes of death for those aged 15-74 years by sex, United Kingdom Atomic Energy Authority establishment, and presence or absence of a radiation record. In general the ratios were low, varying from 64 to 92, with no consistent differences between establishments or between subjects with and without a radiation record. The overall standardised mortality ratio of 74 increased only slightly to 76 after adjusting for social class and region of residence, because of two opposing influences: social class adjustment raised the ratio by reducing the numbers of expected deaths, whereas regional adjustment for mortality in Dounreay increased the numbers of expected deaths, consequently lowering the ratio. Table III shows the standardised mortality ratios for cancers in particular and other causes of death in general. Standardised mortality ratios for all malignant neoplasms, all diseases of the nervous, circulatory, respiratory, digestive, and genitourinary systems, and accidents (151) 73 (28) 79 (46) 21 (2) - (0) 70** (55-88) Intestinal cancer (152) (153) 119 (24) 81 (26) 105 (13) 47 (1) 96 (74-122) Rectal cancer (154) 121 (18) 68 (16) 18* (1) 104 (1) 80 (56-111) Pancreatic cancer (157) 124 (17) 81 (18) 78 (4) - (0) 93 (66-127) Lung cancer (162) 74** (103) 69** (151) 99 (18) 64 (2) 72** (64-81) Bone cancer (170) 56 (1) 73 (2) 141 (1) - (0) 74 Connective and soft tissue cancer (171) 104 (1) 120 (2) - (0) - (0) 91 (19-266) Breast cancer (174) 469 (2) - (0) 93 (38) 55 (4) (185) 79 (9) 115 (19) --100 (67-145) Testicular cancer (186) 173 (4) 142 (6) -
Bladder and urinary cancer (188-189) 88 (15) 66 (18) 27 (1) - (0) 70* (49-98) Brain and other central nervous system cancer (191) (192) 85 (8) 30** (5) 66 (3) 353 (3) 60* (36-93) Thyroid cancer (193) 158 (1) 192 (2) - (0) - (0) 122 All lymphatic and haematopoietic neoplasms (200) (201) (202) 99 (22) 92 (35) 136 (14) 159 (3) 102 (80-128)
Non-Hodgkin's lymphoma (200, 202) 88 (5) 121 (12) 119 (3) - (0) 107 (66-166) Hodgkin's disease (201) 69 (3) 39 (3) 177 (3) 295 (1) 71 (34-131) Multiple myeloma (203) 134 (4) 60 (3) 69 (1) - (0) 83 (36-163) Leukaemia (204) (205) (206) (207) 115 (10) 110 (16) 160 (7) 247 (2) 123 (86-171)
All benign and unspecified neoplasms (210-239)
163 (7) 43 (3) 142 (4) - (0) 96 (52-161) All diseases of the nervous system (320-389) 50* (8) 62 (16) 42 (4) - (0) There were no major differences in mortality between those with and those without a radiation record. The only significant differences (p < 0 05) between the two groups of workers were for uterine and ovarian cancer and benign and unspecified tumours. When examined separately standardised mortality ratios from each of the three main sites of genital tract cancer in women-the cervix (ICD 180), body of the uterus (ICD 182), and ovary (ICD 183)-were higher in women with a radiation record than in those without, only the excess of uterine body cancer being significant at the 5% level. Tables V and VI show the results of "internal" analyses in employees who had a radiation record, comparing mortality at all ages in each of five cumulative exposure categories, adjusting simultaneously for age, sex, social class, calendar period, and establishment. The numbers of expected deaths in tables V and VI were calculated from within the United Kingdom Atomic Energy Authority population, without reference to national mortality rates (see Methods), and thus differ from the numbers of expected deaths in the standardised mortality ratio analyses of the other tables. Although not presented here, standardised mortality ratios at ages 15-74 years were also calculated for each exposure category and exhibited similar trends to those shown in tables V and VI. Table VII shows the standardised mortality ratios in subjects who were monitored for possible contamination by radionuclides or who had any single dosimeter reading exceeding 10 mSv (1 rem). Many workers were monitored for exposure to more than one radionuclide.
The only striking findings were for cancer of the prostate. Mortality from this malignancy was significantly related to cumulative radiation exposure, as measured by personal dosimeter, irrespective of whether no latency ( 130 (16) 1586 (9) Pancreatic cancer (157) fYNo 161 (10) 87 (6) 99 (5 YNeos 1604 (2) 187 (5) 145 ( [No 159 (20) 91 (11) 76 (5) All L~~~~~~~~~~~~~Y e s 72 (5) 84 (13) 117 (18) Non-Hodgkin's lymphoma (200, 202) [No 129 (4) 33 (1) 169 (3) (191) (192) 1-03 (7) Harwell 27 * 10 mSv =1 rem.
+52-2 for all cancers. The slopes of 2-2 for leukaemia and 
Discussion
These 39 546 employees of the United Kingdom Atomic Energy Authority make up the largest British workforce whose mortality has been reported in relation to occupational exposure to low dose radiation. The Hanford study, from the United States, was of comparable size and concerned broadly similar exposures to penetrating radiation.' The mortality among 11 500 men employed by British Nuclear Fuels has also been described.'8 Validation of data and an independent ascertainment of the cause of death were considered to be important aspects of the United Kingdom Atomic Energy Authority study, and each stage of data collection was scrutinised and checked by the Epidemiological Monitoring Unit. The data analysed here were judged to be of good quality, after exclusion of subjects last employed at Risley and Culcheth, where data were missing. This necessarily meant the exclusion of an unknown number who had previously been employed at other United Kingdom Atomic Energy Authority establishments. Much of the work at Risley and Culcheth is administrative: only 30% of employees with existing personnel records also had a radiation record, and their mean cumulative exposure (8-4 mSv) was considerably lower than that in the remaining population (table I) . Validation checks showed that a small number of employees regarded as alive in the analyses may in fact be dead. Inclusion of the 70 deaths (53 in those aged under 75) listed in the appendix, but not used in the analyses, would have increased the standardised mortality ratios for all causes by 3%, not altering the results substantially.
COMPARISON WITH THE GENERAL POPULATION
Employees of the United Kingdom Atomic Energy Authority have generally lower mortality rates than those prevalent in England and Wales, but in the range that might be expected given the nature of the population studied. Their favourable mortality ratios result partly from the social class distribution of the employees (see our accompanying report) and partly from the small underascertainment of deaths, but mostly because normal working populations are known to have low standardised mortality ratios, since they are initially selected from the healthy.1 National statistics include the chronically sick and unemployed, who have higher mortality rates than average. Less is known about how selective forces determining 17 AUGUST 1985 AA45r radiation exposure at Harwell and adjacent authority establishments. Short term employees who had no radiation record were an anomalous group, experiencing high mortality from several causes, especially leukaemia (table IV) . Furthermore, those with and without radiation records showed different trends in mortality from all causes and leukaemia, according to duration of employment. It is not clear why these differences existed and we plan to examine them further in a separate publication. Employees with a radiation record were predominantly scientists, technicians, and skilled workers who had relatively long durations of employment, whereas those without a radiation record were largely in clerical or administrative jobs and were employed for comparatively shorter periods (see our accompanying report). Also the two groups were defined in different ways. An employee "with a radiation record" was one for whom a positive link between a personnel and radiation record was established at the time of data collection, whereas one "without a radiation record" was defined by default (2) . tional groups exposed to low levels of ionising radiationfor example, at British Nuclear Fuels' 8 it should be possible to obtain more complete information on occupational exposure and more precise estimates of radiation associated risks. A study four times as large as this one, with findings similar to those in figures 1 and 2, would show that the figures of the International Commission on Radiological Protection do not underestimate risk by a factor of 10; a study 30 times as large, with such findings would show that the risks are significantly greater than the commission's estimates.
